Abstract 4357398: Artificial-Intelligence Based Smart Catheter Guidance for Atrial Fibrillation Ablation: Large Registry Validation

S Samuel Ruiperez-Campillo (Stanford University, Mountain View, California, United States) T Thomas Fillon (PhysCade, PALO ALTO, California, United States) C Chad Brodt (Silicon Valley Cardiology, Palo Alto, California, United States) M Mitchell Faddis (Washington University Med School, Saint Louis, Missouri, United States) S Sanjiv Narayan (STANFORD MEDICINE, Stanford, California, United States)

Abstract

Background: Ablation of atrial fibrillation (AF) by pulmonary vein (PV) isolation has limited success in some patients. However, identifying additional ablation targets in such patients currently requires mapping the entire atrium, which is time-consuming and poorly accounts for real-time changes. Objectives: We developed an Artificial-Intelligence (AI) based system that can guide an electrophysiology catheter in real-time (i.e. left/right, superior/inferior) during AF from an arbitrary location directly to sites leading to AF termination or 1Y success (fig. A). We validated the system in a large registry, and evaluated projected time savings from this approach. Methods: coPilot is an AI-system developed and tested in separate cohorts on ~20 million electrograms in a N=236 patient registry with physiological and clinical ground truth labels. First, we trained recurrent neural network (RNN) models to estimate AF activation times using unipolar and bipolar electrogram features (first derivative dV/dt, shape), tuned in a random forest classifier to experts informed by monophasic action potential (MAP) tracings (fig. B; top). Second, we applied this AI-model to multi-electrode catheters (e.g. local HDGrid, global Basket), to calculate predominant AF wave direction (fig. B bottom). Third, we validated if moving a catheter in AI-indicated directions reached successful AF ablation sites in a hold-out set not used for training. Results: The validation cohort was 69.0±8.3 years’ and 72.6% had non-paroxysmal AF. In Fig. B, AF activation times by traditional electrogram features were noisy versus MAPs (arrows). Fig. B (bottom) shows AI-activation times on a multi-electrode array in a 67Y woman in persistent AF, showing predominantly up/left activity over time. The array was moved accordingly and analysis repeated (steps 1-4 in fig. A, top), until the AF termination site was reached. coPilot pointed to 85.7% of AF termination versus 13.1% of control sites (p<0.01, fig. C). coPilot also reached sites ablated in cases of long-term success (68.8% at 1Y). Time to the successful region was 4.2±1.1 movements (estimated <5 minutes) that was shorter than atrial mapping time (>10-15 minutes). Conclusions: A novel AI-based system trained to physiological and clinical gold standards can rapidly steer a clinical catheter during AF to successful ablation sites. This approach has promise for improving the success of AF ablation while reducing case time over existing strategies.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (5)

S

Samuel Ruiperez-Campillo

Stanford University, Mountain View, California, United States

T

Thomas Fillon

PhysCade, PALO ALTO, California, United States

C

Chad Brodt

Silicon Valley Cardiology, Palo Alto, California, United States

M

Mitchell Faddis

Washington University Med School, Saint Louis, Missouri, United States

S

Sanjiv Narayan

STANFORD MEDICINE, Stanford, California, United States